XML 36 R21.htm IDEA: XBRL DOCUMENT v3.25.1
Insider Trading Arrangements
 3 Months Ended
Apr. 04, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Amy C. Peterson [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Amy C. Peterson, our Executive Vice President, Product Development and Medical Affairs, and Chief Medical Officer, an officer for purposes of Section 16 of the Exchange Act, entered into a pre-arranged stock trading plan on February 13, 2025. Ms. Peterson’s trading plan provides for the sale of up to 72,776 shares of our common stock (including shares obtained from the exercise of vested stock options covered by the trading plan) between May 16, 2025 and March 2, 2026. This trading plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and Exelixis’ policies regarding transactions in Exelixis securities.
Name Amy C. Peterson
Title Executive Vice President, Product Development and Medical Affairs, and Chief Medical Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 13, 2025
Expiration Date March 2, 2026
Arrangement Duration 290 days
Aggregate Available 72,776